FDA inspection
Saving Sight: FDA inspection ending Feb 25, 2026
FDA inspection 1308808 · No Action Indicated (NAI) · Kansas City, MO
Key facts
| Inspection ID | 1308808 |
|---|---|
| Firm | Saving Sight |
| FEI number | 3003347229 |
| Address | 10560 N Ambassador Dr Ste 210 |
| City | Kansas City |
| State | MO |
| ZIP | 64153 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Feb 25, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data